Faruqi & Faruqi, LLP is Investigating United Therapeutics Corporation (UTHR) on Behalf of its Shareholders

News provided by

Jan 17, 2018, 04:02 ET

NEW YORK, Jan. 17, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQ: UTHR).

The investigation focuses on whether the Company and/or its directors and officers breached their fiduciary duties.

Request more information now by clicking here: www.faruqilaw.com/UTHR. There is no cost or obligation to you.

Take Action

If you currently own United Therapeutics stock and would like to discuss your legal rights, please visit www.faruqilaw.com/UTHR. You can also contact us by calling Nina Varindani, Esq. either via e-mail at [email protected] or by telephone at (877) 247-4292 or (212) 983-9330 or Michael Van Gorder, Esq. at [email protected].

Faruqi & Faruqi, LLP also encourages anyone with information regarding the Company's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

Nina Varindani, Esq.
Michael Van Gorder, Esq.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Telephone: (877) 247-4292 or (212) 983-9330
[email protected]
[email protected]

SOURCE Faruqi & Faruqi, LLP